glp 1 2024 The percentage of U.S. adults who currently take GLP-1 medications for weight loss purposes has risen to 11% in 2026, up significantly from 3% in 2024. And 15% report having used the 2024 in Review: The Rise

Hormonal Imbalances Persist If hormonal imbalances (cortisol, thyroid, sex hormones, leptin) contributed to your weight gain, they are still present after you stop GLP-1

It's very rewarding because we get to teach them and learn from them on the latest studies and techniques

Are GLP-1 agonists safe for everyone

Wegovy, a higher-dose formulation of semaglutide, is specifically approved for weight management

Furthermore, the growing trend toward personalized medicine and lifestyle interventions accelerated Semaglutide's uptake among healthcare professionals and patients alike

This is a wild statistic: Only 26% of women have their menopause-related prescriptions fully covered by insurance, and 8% dont have their prescriptions covered at all